The abstract is read at the publisher; the summary is JClub's.
A harmonized plasma proteomic atlas spanning over 10,000 proteins across 27 rare genetic neurodevelopmental disorders finds two convergent proteomic clusters separated by a dominant axis.
- Why it matters: Individual disorders are too small for well-powered biomarker work, so shared downstream biology and cross-disorder severity signals remain hard to detect.
- What they did: The study measured plasma proteomes and standardized adaptive behaviour in unaffected family members, then performed differential abundance in 26 disorders and built a multivariate severity index from held-out data.
- The result: Proteomic clustering is independent of gene function and clinical classification, epilepsy shows a reproducible cross-disorder signature, and protein-based severity tracks adaptive communication ability within diagnoses.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.